All terms in EFO
| Label | Id | Description |
|---|---|---|
| vitamin K-dependent protein C measurement | EFO_0008318 | [quantification of the amount of vitamin K-dependent protein C in a sample] |
| WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 measurement | EFO_0008319 | [quantification of the amount of WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 in a sample] |
| Actinobacillus pleuropneumoniae serovar 5 | NCBITaxon_44294 | |
| toll-like receptor 4:Lymphocyte antigen 96 complex measurement | EFO_0008301 | [quantification of the amount of toll-like receptor 4:Lymphocyte antigen 96 complex in a sample] |
| brachiocephalic artery | UBERON_0001529 | [The short first aortic arch branch and divides into the right subclavian artery and the right common carotid artery.] |
| transforming growth factor-beta-induced protein ig-h3 measurement | EFO_0008302 | [quantification of the amount of transforming growth factor-beta-induced protein ig-h3 in a sample] |
| transmembrane glycoprotein NMB measurement | EFO_0008303 | [quantification of the amount of transmembrane glycoprotein NMB in a sample] |
| trefoil factor 3 measurement | EFO_0008304 | [quantification of the amount of trefoil factor 3 in a sample] |
| TNF-related apoptosis-inducing ligand measurement | EFO_0008300 | [quantification of the amount of TNF-related apoptosis-inducing ligand in a sample] |
| tumor necrosis factor receptor superfamily member 19L measurement | EFO_0008309 | [quantification of the amount of tumor necrosis factor receptor superfamily member 19L in a sample] |
| trypsin-2 measurement | EFO_0008305 | [quantification of the amount of trypsin-2 in a sample] |
| tryptase beta-2 measurement | EFO_0008306 | [quantification of the amount of tryptase beta-2 in a sample] |
| tuberculin skin test reactivity measurement | EFO_0008307 | [quantification of the severity of the skin reaction in response to the injection of TB antigen] |
| tumor necrosis factor beta measurement | EFO_0008308 | [quantification of the amount of tumor necrosis factor beta in a sample] |
| panic disorder with agoraphobia | EFO_1001906 | [A disorder in which an individual experiences recurrent, unexpected panic attacks and persistent concern about having additional panic attacks. Agoraphobia is a component of this disorder.] |
| panic disorder | EFO_0004262 | [An anxiety disorder characterized by multiple unexpected panic attacks with persistent concern of recurring attacks. Panic disorder may or may not be accompanied by agoraphobia., A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.] |
| X-12261 measurement | EFO_0021301 | [Quantification of the amount of X-12261 in a sample.] |
| Oxidative Stress | EFO_1001905 | [A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).] |
| X-12253 measurement | EFO_0021300 | [Quantification of the amount of X-12253 in a sample.] |
| oral mucositis | EFO_1001904 | [Inflammation of the mucous membranes of any of the structures in the mouth.] |